Hepatitis C virus (HCV) is a human hepatotropic virus, but many hepatoma cell lines are not permissive to this virus. In a previous study, we observed that SNU-182, SNU-398 and SNU-449 hepatoma cell lines were nonpermissive to HCV. To understand the nonpermissivity, we evaluated the ability of each cell line to support the different steps of HCV life cycle (entry, replication and production of infectious particles). Using 
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Hepatitis C virus (HCV) is a human hepatotropic virus, but many hepatoma cell lines are not permissive to this virus. In a previous study, we observed that SNU-182, SNU-398 and SNU-449 hepatoma cell lines were nonpermissive to HCV. To understand the nonpermissivity, we evaluated the ability of each cell line to support the different steps of HCV life cycle (entry, replication and production of infectious particles). Using retroviral pseudoparticles pseudotyped with HCV envelope proteins and recombinant HCV produced in cell culture, we observed that low level or absence of claudin-1 (CLDN1) expression limited the viral entry process in SNU-182 and SNU-398 cells, respectively. Our results also showed that supplementation of the three cell lines with miR-122 partly restored the replication of a JFH1 HCV replicon. Finally, we observed that expression of apolipoprotein E (ApoE) was very low or undetectable in the three cell lines and that its ectopic expression permits the production of infectious viral particles in SNU-182 and SNU-398 cells but not in SNU-449 cells. Nevertheless, the supplementation of SNU-182, SNU-398 and SNU-449 cells with CLDN1, miR-122 and ApoE was not sufficient to render these cells as permissive as HuH-7 cells. Thus, these cell lines could serve as cell culture models for functional studies on the role of CLDN1, miR-122 and ApoE in HCV life cycle but also for the identification of new restriction and/or dependency host factors essential for HCV infection.
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| INTRODUCTION
Hepatitis C virus (HCV) is an important human pathogen. Worldwide, over 170 million people are chronically infected. Furthermore, 75% to 80% of HCV-infected patients develop chronic infection, which may lead to cirrhosis and, ultimately, hepatocellular carcinoma. HCV is a small enveloped positive-strand RNA virus of the Flaviviridae family, classified in the Hepacivirus genus. The study of HCV infection has long been limited by the absence of complete in vitro cell culture system. However, several alternative tools were developed in the two past decades to understand the HCV life cycle. First, the establishment of subgenomic replicons that autonomously amplify in cultured human hepatoma cells allowed to understand the mechanisms of HCV genome replication.
2 Then, the generation of infectious retroviral pseudotypes displaying functional HCV glycoproteins (HCVpp) allowed for the study of HCV entry. cloning of the genotype 2a JFH1 strain finally paved the way for the production of infectious HCV virions (HCVcc) and the investigation of the full viral cycle in human liver cancer-derived HuH-7 cells. 5, 6 Thanks to these models, substantial progress has been made in the identification of host factors involved in HCV propagation. Among them, CD81, the scavenger receptor class B type I (SR-BI), claudin-1 (CLDN1), occludin (OCLN) and Niemann-Pick C1-like 1 (NPC1L1) were identified as important HCV entry factors. 7 The liver-specific microRNA miR-122
has been shown to be one of the most important host factors for HCV replication. 8 Furthermore, components of the very low-density lipoprotein biosynthesis pathway such as apolipoprotein E (ApoE) have been shown to be important for the assembly and release of infectious viral particles.
9-12
The use of nonpermissive cells is an interesting tool to identify new host restriction or dependency factors for viral permissivity. In a previous study, we reported that the SNU-182, SNU-398
and SNU-449 hepatocarcinoma cell lines were not able to support HCV infection. 13 In this work, we evaluated the ability of each cell line to support specific steps of HCV lifecycle (ie, entry, replication and production of infectious particles) and tried to identify the host factors that prevent these cell lines from being infected by this virus. 
| MATERIALS AND METHODS

| Cell culture
| Hepatitis C virus
We used two recombinant viruses derived from the JFH1 strain and expressing a Renilla luciferase reporter gene, the JFH1-CS-A4-RLuc/ TM construct 13 and the JFH1-CS-A4-RLuc/QM construct, which contain the additional mutation I414T in E2, as compared to the JFH1-CS-A4-RLuc/TM strain. 
| Recombinant hepatitis C virus produced in cell culture and retroviral particles pseudotyped with hepatitis C virus envelope proteins infection
| Quantification of miR-122 expression
The expression of miR-122-5p (assay ID: 002245) was quantified by RT-qPCR using the TaqMan 
| Flow cytometry
The CD81 cell surface expression was assessed by flow cytometry.
Cells were trypsinized, centrifuged, resuspended in PBS and stained with isotype control or FITC-coupled anti-CD81 mouse monoclonal antibody (JS-81, BD Pharmingen). Samples were analysed on a Navios flow cytometer (Beckman Coulter, Brea, CA, USA). 
| Claudin-1, apolipoprotein E and miR-122 transductions
| Western blot analysis
Cells were lysed with RIPA buffer. Protein content of cell lysates was 
| Statistical analysis
| RESULTS
| SNU-182, SNU-398 and SNU-449 cells are not permissive to hepatitis C virus entry and replication
In a previous study, we used the RFP-NLS-IPS HCV infection reporter system 16 and observed that SNU-182, SNU-398 and SNU-449 cells
were not permissive to HCV infection. 13 This result indicated that the entry step and/or the replication step could not be achieved in these cells. To determine which step was affected, we first assessed HCV entry using HCVpp and pseudoparticles lacking envelope (Δenvpp) or noninfected cells as negative controls. As shown in Figure 1A Altogether, these results suggested that both the entry and replication steps of HCV life cycle are blocked in SNU-182, SNU-398 and SNU-449 cells.
| Stable expression of miR-122 partly restored hepatitis C virus RNA replication in SNU-182, SNU-398 and SNU-449 cells
Deficiency in miR-122 expression has been shown to be responsible for the absence of HCV RNA replication in several cell lines. Recently, it has also been shown that SEC14L2 enables pangenotype HCV replication in cell culture. 21 We thus investigated whether transduction of SEC14L2 in SNU-182, SNU-398 and SNU-449 cells could improve HCV replication but we did not observe any effect (data not shown). However, this result was predictable as Saeed et al also mentioned that replication of the JFH-1 strain was not enhanced by SEC14L2. We also wondered whether induction of the innate immune response could be responsible for the low replication level; however, we did not detect any induction of interferon-β and interferon-λ mRNA expression after infection (data not shown). This was corroborated by the fact that the use of pyridone-6, an inhibitor of the Janus kinases involved in the interferon-mediated signalling, did not increase the replication level (data not shown). Differences were considered statistically significant if P < .05 (*) or P < .01 (**)
Finally, as low levels of replication were achieved in SNU-182, SNU-398 and SNU-449 cells transduced with miR-122, we wondered whether they were able to assemble and secrete progeny virions. However, we did not detect any infectious particle production ( Figure 2D ) and levels of extracellular core protein remained very low or undetectable ( Figure 2C ).
| Claudin-1 transduction improves hepatitis C virus entry in SNU-182-miR-122 and SNU-398-miR-122 cells
To understand HCV entry defect in SNU-182, SNU-398 and SNU-449 cells, we evaluated the expression level of several cellular entry factors. Flow cytometry analysis revealed that CD81 is correctly expressed at the surface of each cell line ( Figure 3A ). In addition, we observed by Western blot using specific antibodies that the three cell lines expressed high levels of SR-BI, OCLN and NPC1L1 ( Figure 3B ). 
| Apolipoprotein E transduction improves infectious virus production in SNU-182-miR-122-claudin-1 and SNU-398-miR-122-claudin-1 cells
As shown in Figure 2B ,D, whereas low levels of HCV RNA replication were achieved in miR-122 transduced SNU-182, SNU-398 and SNU-449 cells, we did not detect any production of progeny virions.
As ApoE is known to be essential for assembly and secretion of new virions, we assessed the expression level of this protein in these cells.
Western blot analysis and ELISA assay suggested that ApoE was not expressed in SNU-398-miR-122-CLDN1 and SNU-449-miR-122 cells whereas it was marginally expressed and secreted by SNU-182-miR-122-CLDN1 cells. We thus tested whether stable expression of exogenous ApoE could help these cells to produce infectious virions. Interestingly, we observed that stable expression of ApoE in SNU-182-miR-122-CLDN1 and SNU-398-miR-122-CLDN1 cells gave rise to a production of progeny virions whereas it had no effect on viral production in SNU-449-miR-122 cells ( Figure 5C ). These results were confirmed by quantification of core in the cell supernatant ( Figure 5D ).
| DISCUSSION
In our previous study, we identified three human hepatocellular carcinoma cell lines established from the primary tumours of Korean patients, SNU-182, SNU-398 and SNU-449, that are not permissive to HCV. 13 For each cell line, we identified the different steps that were compromised and tried to decipher the mechanisms of the impairments (cf summary Table 1 ).
We first observed that defect in CLDN1 expression was responsible for the inefficiency of the entry step in SNU-182 and SNU-398.
We also demonstrated that its ectopic expression renders these cells permissive to this step. CLDN1 was identified as an HCV entry factor thanks to a cyclic lentivirus based repackaging screen of a complementary DNA library, derived from the highly HCV-permissive hepatocarcinoma Huh-7.5 cell line, for genes that render the 293T cell line permissive to HCVpp. 22 For this reason, 293T cells are widely used to perform functional studies on the role of CLDN1 in HCV entry. It has also been shown that CLDN1 expression alone conferred limited permissiveness for HCV infection in these cells and that co-expression of CD81, OCLN and SR-BI enhance HCV entry to a level higher than that in Huh7.5.1 cells. 20 However, it has to be kept in mind that many clones of 293T cells exist which may explain some discrepancies between studies. Other models such as H1H or HuH6 cells have been used, 23, 24 and in this study, we identified SNU-182 and SNU-398 cells as alternative cell culture models, expressing high levels of CD81, OCLN, SR-BI and NPC1L1, to perform functional studies of the role of CLDN1 in HCV entry.
MiR-122 is an abundant, liver-specific miRNA that is an unusual host factor for HCV. This miRNA binds HCV RNA and slows decay of the viral genome through protection from 5′ exonuclease activity of the host mRNA decay machinery. 25 Many studies demonstrated that supplementation of several nonpermissive cell lines with miR-122 renders them permissive for transient replication of HCV RNA. [17] [18] [19] [20] [26] [27] [28] In this study, we observed that miR-122 is expressed at a low level in However, it is difficult to evaluate precisely the efficiency of this step because of the low level of replication.
Altogether, our results identified SNU-182, SNU-398 and SNU-449 cells as hepatocarcinoma cell lines that can be used as models for the study of the functional role of CLDN1, miR-122 and ApoE in the entry, replication and assembly step of HCV life cycle. These cell lines could also be used to identify new dependency/restriction host factors essential for the different step of the viral cycle, thanks to screening strategies, as described previously.
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